Clinical Trials for Fortrea

Explore 21 clinical trials worldwide

Showing 1-21 of 21 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Fortrea

Clinical Trials (21)

NCT07219238
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
PHASE2/PHASE3Not yet recruiting
175 participants
Started: Mar 31, 2026 · Completed: Aug 31, 2029
4 conditions2 sponsors2 locations
NCT07109219
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
PHASE1/PHASE2Not yet recruiting
83 participants
Started: Oct 31, 2025 · Completed: Jul 3, 2028
1 condition2 sponsors22 locations
NCT07093398
A Phase 1 Study to Assess Food Effect on the Pharmacokinetics of D3S-001 in Healthy Adult Participants
PHASE1Recruiting
14 participants
Started: Jul 11, 2025 · Completed: Jan 30, 2026
1 condition2 sponsors2 locations
NCT06933472
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
PHASE3Recruiting
264 participants
Started: Jun 13, 2025 · Completed: Jan 10, 2027
4 conditions2 sponsors31 locations
NCT06916806
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies.
PHASE1Recruiting
54 participants
Started: May 1, 2025 · Completed: Jun 22, 2027
2 conditions2 sponsors29 locations
NCT06713369
AZD5305 hADME in Patients With Advanced Solid Malignancies
PHASE1Recruiting
8 participants
Started: Apr 2, 2025 · Completed: Oct 2, 2026
1 condition2 sponsors2 locations
NCT06651970
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
PHASE4Recruiting
60 participants
Started: Feb 4, 2025 · Completed: Aug 16, 2030
2 conditions5 sponsors23 locations
NCT06769633
Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old
PHASE2Recruiting
18 participants
Started: Jan 2, 2025 · Completed: Dec 31, 2029
1 condition2 sponsors9 locations
NCT06706817
A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab
PHASE3Recruiting
180 participants
Started: Dec 3, 2024 · Completed: Jan 29, 2027
1 condition2 sponsors44 locations
NCT06495918
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration
PHASE3Active, not recruiting
825 participants
Started: Nov 27, 2024 · Completed: Jan 8, 2027
1 condition3 sponsors97 locations
NCT06473779
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
PHASE3Recruiting
300 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors85 locations
NCT06563102
Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
PHASE4Recruiting
100 participants
Started: Sep 11, 2024 · Completed: Feb 20, 2026
1 condition2 sponsors19 locations
NCT06398730
A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers
PHASE1Recruiting
24 participants
Started: Jul 2, 2024 · Completed: Jan 31, 2026
1 condition3 sponsors1 location
NCT05933057
Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
PHASE3Recruiting
138 participants
Started: Feb 19, 2024 · Completed: Feb 29, 2028
1 condition2 sponsors20 locations
NCT06223958
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration
PHASE3Active, not recruiting
344 participants
Started: Jan 29, 2024 · Completed: Sep 27, 2027
1 condition3 sponsors108 locations
NCT06083012
Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation
N/ARecruiting
150 participants
Started: Oct 27, 2023 · Completed: Apr 27, 2027
3 conditions2 sponsors7 locations
NCT05693129
Pediatric Patients Aged 1 to 6 Years With APDS
PHASE3Active, not recruiting
16 participants
Started: Aug 30, 2023 · Completed: Feb 28, 2026
1 condition5 sponsors9 locations
NCT06398743
First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer
N/AActive, not recruiting
416 participants
Started: Jun 20, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors22 locations
NCT05438407
Pediatric Patients Aged 4 to 11 Years With APDS
PHASE3Active, not recruiting
15 participants
Started: Feb 1, 2023 · Completed: Dec 30, 2025
1 condition5 sponsors7 locations
NCT04755283
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
PHASE2Active, not recruiting
1,287 participants
Started: Feb 2, 2021 · Completed: Dec 29, 2028
2 conditions3 sponsors92 locations
NCT04498026
Adherus™ Dural Sealant in Spinal Procedures
NAEnrolling by invitation
114 participants
Started: Nov 19, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors14 locations